hospit
infect
preval
survey
perform
univers
medic
centr
hong
kong
investig
rate
four
major
hospitalacquir
infect
hai
pneumonia
symptomat
urinari
tract
infect
surgic
site
infect
laboratoryconfirm
bloodstream
infect
order
identifi
current
distribut
chang
year
oneday
point
preval
studi
perform
septemb
inpati
survey
hai
communityacquir
infect
cai
risk
factor
pathogen
isol
antibiot
prescrib
infect
diagnos
accord
center
diseas
control
prevent
cdc
criteria
total
patient
survey
hai
preval
receiv
antibiot
commonest
hai
pneumonia
follow
bloodstream
infect
symptomat
urinari
tract
infect
preval
postop
surgic
site
infect
nosocomi
preval
rate
highest
intens
care
unit
follow
pediatr
neonat
intens
care
unit
children
cancer
centrebon
marrow
transplant
unit
orthopaed
traumatolog
meticillinresist
staphylococcu
aureu
pseudomona
aeruginosa
commonest
pathogen
rate
significantli
lower
previous
reflect
increas
resourc
infect
control
made
avail
follow
outbreak
sever
acut
respiratori
syndrom
sar
hospitalacquir
infect
hai
common
caus
morbid
mortal
among
hospit
patient
surveil
nosocomi
infect
ni
import
compon
effect
infect
control
programm
nation
nosocomi
infect
surveil
nni
system
coupl
feedback
intervent
success
reduc
infect
rate
among
particip
hospit
unfortun
prospect
surveil
costli
labour
intens
preval
survey
rel
inexpens
easi
perform
although
rate
obtain
higher
compar
incid
rate
may
statist
less
stabl
despit
limit
provid
use
estim
hai
french
et
al
conduct
serial
point
preval
survey
hospit
year
ago
prove
practic
use
way
document
trend
hai
assess
impact
infect
control
programm
conduct
preval
survey
also
rais
awar
among
healthcar
profession
infect
risk
hospit
set
object
studi
determin
rate
nosocomi
infect
use
antibiot
knowledg
current
situat
major
chang
distribut
nosocomi
infect
help
priorit
resourc
alloc
allow
effect
infect
control
polici
enabl
target
prospect
surveil
programm
princ
wale
hospit
pwh
teach
hospit
hong
kong
laboratori
accredit
nation
associ
test
author
nata
offer
wide
rang
bacteriolog
virolog
servic
studi
perform
septemb
inpati
document
hospit
comput
system
includ
except
temporarili
observ
accid
emerg
depart
cdc
definit
nosocomi
infect
use
hai
defin
occurr
infect
hospit
admiss
without
evid
infect
present
incub
h
admiss
four
major
infect
survey
pneumonia
symptomat
urinari
tract
infect
suti
surgic
site
infect
ssi
laboratoryconfirm
bloodstream
infect
lcbsi
infect
one
site
patient
count
separ
infect
activ
infect
ie
undergo
antimicrobi
treatment
symptomat
consid
ongo
medic
staff
includ
demograph
inform
admiss
diagnosi
use
medic
devic
antibiot
record
ward
nurs
staff
attend
brief
session
ward
point
preval
survey
instruct
correct
fill
data
collect
form
relev
data
record
investig
infect
control
nurs
medic
microbiologist
total
separ
standard
data
collect
form
visit
ward
examin
clinic
record
microbiolog
result
drug
chart
return
visit
made
patient
medic
record
avail
complet
data
collect
form
check
day
survey
coordin
avoid
absenc
data
microbiolog
data
collect
two
week
studi
period
statist
analysi
conduct
use
spss
softwar
spss
inc
chicago
il
usa
p
consid
statist
signific
result
fed
back
hospit
infect
control
committe
individu
depart
survey
patient
survey
distribut
specialti
shown
tabl
age
rang
day
year
mean
median
age
year
respect
male
femal
hospit
rang
day
patient
admit
two
day
less
nearli
admit
day
less
mean
median
durat
hospit
four
day
respect
patient
devic
present
peripher
intraven
cathet
n
urinari
cathet
n
central
venou
cathet
n
common
patient
one
devic
two
patient
three
twenti
patient
receiv
mechan
ventil
fortyfour
hai
diagnos
patient
two
patient
acquir
infect
anoth
hospit
exclud
leav
hai
patient
give
hai
rate
common
hai
pneumonia
follow
ssi
lcbsi
final
suti
tabl
two
case
ventilatorassoci
pneumonia
vap
among
case
hospitalacquir
pneumonia
hap
fiftyseven
percent
hospitalacquir
urinari
tract
infect
cathet
relat
icu
highest
preval
rate
nosocomi
infect
follow
pediatricneonat
icu
children
cancer
centr
bone
marrow
transplant
unit
cccbmt
orthopaed
traumatolog
tabl
preval
ssi
among
patient
undergon
oper
tabl
approxim
surgic
patient
underw
oper
classifi
contamin
dirti
diagnos
ssi
four
percent
clean
cleanecontamin
oper
ssi
tabl
patient
nosocomi
infect
median
hospit
stay
day
compar
day
noninfect
patient
durat
hospit
stay
oper
invas
ventil
intravascular
devic
independ
risk
factor
hai
p
tabl
ii
sixtysix
patient
diagnos
cai
preval
rate
togeth
hai
patient
hai
two
patient
hai
hospit
overal
preval
rate
infect
hospit
among
patient
hai
relev
microbiolog
serolog
test
perform
posit
cultur
commonest
organ
isol
pseudomona
aeruginosa
meticillinresist
staphylococcu
aureu
total
patient
receiv
antibiot
receiv
one
antibiot
receiv
two
receiv
three
five
commonli
prescrib
antibiot
amoxicillinclavulan
metronidazol
cefuroxim
cloxacillin
gentamicin
tabl
iii
commonest
antibiot
combin
cefuroxim
metronidazol
n
gentamicin
penicillin
n
ampicillin
cloxacillin
n
ampicillin
cefuroxim
metronidazol
n
gentamicin
vancomycin
n
though
find
similar
part
world
use
local
healthcar
worker
last
survey
hospit
perform
year
ago
interest
chang
nosocomi
infect
rate
antibiot
use
found
differ
methodolog
patient
popul
allow
stringent
comparison
preval
differ
survey
meaning
comparison
infect
rate
requir
adjust
intrins
extrins
risk
factor
impact
case
mix
infect
rate
well
illustr
exampl
hospit
size
studi
sax
group
detail
inform
patient
demograph
durat
hospit
stay
invas
devicesantibiot
use
illustr
refer
singl
hospit
studi
cdc
definit
infect
adopt
although
use
previou
survey
one
wide
use
object
standard
investig
qualifi
medic
nurs
staff
relev
infect
control
train
interobserv
bia
minim
ensur
investig
agre
interpret
diagnost
criterion
survey
howev
gastmeier
et
al
show
despit
use
specif
cdc
criteria
could
still
subject
diagnosi
nosocomi
infect
investig
effect
known
current
survey
four
major
infect
studi
preval
hai
point
preval
survey
use
cdc
diagnost
criteria
involv
four
major
site
infect
suti
lrti
ssi
bsi
conduct
franc
itali
norway
lebanon
preval
hai
rang
inclus
site
infect
tend
increas
overal
preval
rate
compar
studi
includ
major
site
thu
correct
hai
preval
rate
estim
site
would
rate
much
lower
found
pwh
well
countri
apart
overal
rate
rate
reduct
found
hap
ssi
uti
without
make
casemix
adjust
figur
probabl
relat
improv
infect
control
follow
sar
crisi
hong
kong
evidenc
increas
resourc
heighten
awar
among
healthcar
worker
hcw
hospit
one
infect
control
nurs
per
bed
compar
previou
ratio
infect
control
programm
alert
organ
report
biannual
hand
hygien
audit
regular
infect
control
educationaltrain
hcw
ssi
surveil
sinc
implement
heighten
infect
control
awar
demonstr
high
complianc
rate
hand
hygien
audit
among
hcw
low
preval
may
also
relat
short
durat
hospit
stay
rapid
transfer
convalesc
hospit
initi
diagnosi
stabil
preval
nosocomi
pneumonia
lcbsi
ssi
similar
report
european
survey
preval
nosocomi
lcbsi
rel
high
possibl
due
high
overal
blood
cultur
rate
simpl
applic
diagnost
criteria
rate
nosocomi
urinari
tract
infect
uti
lower
report
survey
greatest
problem
defin
suti
urin
analyz
uti
diagnos
secondli
definit
take
account
urinari
cathet
symptom
uti
fever
assess
catheter
patient
frequenc
suti
therefor
depend
upon
frequenc
cathet
use
patient
indwel
urinari
cathet
ii
urin
analysi
protocol
hospit
urin
analys
sign
symptom
indic
uti
catheter
patient
develop
fever
symptom
uti
patient
seriou
major
diseas
organ
may
ignor
iii
physician
diagnosi
data
collect
base
doctor
diagnosi
may
sensit
enough
record
uti
furthermor
asymptomat
bacteriuria
evalu
factor
may
account
underestim
rate
uti
compar
studi
distribut
nosocomi
infect
among
differ
specialti
similar
publish
european
studi
preval
nosocomi
infect
greatest
icu
compar
year
ago
similar
studi
special
pediatr
unit
rank
second
nosocomi
infect
hai
limit
ssi
shown
twice
common
postop
patient
thirtyeight
percent
patient
receiv
least
one
antimicrobi
agent
studi
infect
accord
cdc
criteria
indic
antibiot
prescript
review
retrospect
order
investig
discrep
tabl
iii
prophylact
use
treatment
infect
investig
current
survey
may
account
antibiot
use
patient
remain
may
repres
treatment
infect
fulfil
cdc
criteria
inappropri
antibiot
prescript
recent
survey
show
suboptim
antimicrobi
prescript
frequent
hospit
though
appropri
antibiot
prescript
aim
current
studi
unnecessari
antibiot
combin
note
tabl
iii
broadspectrum
antibiot
eg
imipenem
meropenem
cefepim
account
antibiot
prescrib
day
survey
audit
biggun
antibiot
local
univers
hospit
reveal
prescript
justifi
suboptim
upcom
antibiot
stewardship
programm
target
group
drug
help
optim
use
antimicrobi
hospit
summari
provis
better
resourc
appear
definit
effect
reduc
hai
icu
special
pediatr
surgic
orthopaed
unit
warrant
target
surveil
nosocomi
infect
follow
relev
infect
control
programm
anoth
target
would
improv
nosocomi
bloodstream
infect
promot
proper
intraven
cathet
care
repeat
preval
survey
use
monitor
trend
rate
hai
effect
intervent
strategi
